137 related articles for article (PubMed ID: 3566306)
1. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
[TBL] [Abstract][Full Text] [Related]
2. [Bestrabacil: a possible target-oriented anticancer agent].
Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
Isurugi K
Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of bestrabucil (KM2210) in bladder cancer].
Nasu Y; Saegusa M; Ochi J; Hara M; Akagi T; Obama T; Yoshimoto J; Matsumura Y; Ohmori H; Tsushima T
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3155-6. PubMed ID: 3674900
[No Abstract] [Full Text] [Related]
5. Antitumor activity and pharmacokinetics of estra-1,3,5 (10)-triene-3,17 beta-diol, 3-benzoate, 17-((4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy) acetate) (Bestrabucil) in human tumor xenografts serially transplanted into nude mice.
Kubota T; Kawamura E; Suzuki T; Yamada T; Toyoda H; Miyagawa T; Kurokawa T
Jpn J Clin Oncol; 1986 Dec; 16(4):357-64. PubMed ID: 3795532
[TBL] [Abstract][Full Text] [Related]
6. [Tumor-oriented anti-cancer agent with estrogen as a carrier].
Ohsawa N; Yamazaki Z
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1065-71. PubMed ID: 3291767
[TBL] [Abstract][Full Text] [Related]
7. [A case of carcinoma in the lower abdomen treated successfully with oral administration of bestrabucil].
Tsujitani S; Baba H; Korenaga D; Haraguchi M; Hiramoto Y; Okamura T; Sugimachi K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2960-3. PubMed ID: 3662547
[TBL] [Abstract][Full Text] [Related]
8. Role of multidrug resistance in tumors of the genitourinary tract.
Theyer G; Hamilton G
Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331
[No Abstract] [Full Text] [Related]
9. [Therapeutic results in recurrent breast cancer with the use of Bestrabucil (KM2210)].
Ueda T; Sakai K; Morimoto K; Nakatani S
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3285-9. PubMed ID: 3688892
[TBL] [Abstract][Full Text] [Related]
10. [Phase I study of bestrabucil (KM 2210)].
Kamei H; Takenaka K; Goto T; Suga S; Fugiwara A; Nakao I; Agatsuma T; Fujita K; Isurugi K; Kubota T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2208-15. PubMed ID: 3755019
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
Naito K; Kubo K; Akao Y; Hiraiwa A; Naoe T; Yamada K
Gan No Rinsho; 1986 Sep; 32(11):1443-50. PubMed ID: 2877106
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1988; 10():271-90. PubMed ID: 2856330
[No Abstract] [Full Text] [Related]
13. Inhibitory effects of bestrabucil, a conjugate of chlorambucil and estradiol, on the production of androgen-induced growth factor(s) by Shionogi carcinoma 115 cells.
Akaza H; Imada S; Tsukamoto S; Koiso K
Int J Urol; 1994 Mar; 1(1):67-73. PubMed ID: 7627841
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of urogenital cancer.
Merrin CE; Murphy GP
Surg Annu; 1976; 8():391-412. PubMed ID: 180617
[No Abstract] [Full Text] [Related]
15. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
16. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
17. The role of chemotherapy in the management of malignant urogenital neoplasms.
Schnipper LE
Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317
[No Abstract] [Full Text] [Related]
18. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
19. [Cytostatic adjuvant therapy of tumors in the urogenital region].
Vahlensieck W
Haematol Blood Transfus; 1978; 22():165-74. PubMed ID: 220154
[No Abstract] [Full Text] [Related]
20. Cancer chemotherapy in urology.
Furnari S; Pavone-Macaluso M; Veroux G; Mattea E
Urol Int; 1971; 26(4):315-20. PubMed ID: 4331514
[No Abstract] [Full Text] [Related]
[Next] [New Search]